Kerntke Otto McGlone Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Kerntke Otto McGlone Wealth Management Group's PFE Position: Q1 2024 in Review
Kerntke Otto McGlone Wealth Management Group sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,387 shares — an estimated $213K sold.
Kerntke Otto McGlone Wealth Management Group first reported a position in PFE in Q4 2019 and held it in 17 quarters. The position peaked at $443K in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Kerntke Otto McGlone Wealth Management Group reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Kerntke Otto McGlone Wealth Management Group sold 7,387 Pfizer shares in Q1 2024, an estimated $213K.
- Kerntke Otto McGlone Wealth Management Group first reported a position in Pfizer in Q4 2019 and held it in 17 quarters.
- Kerntke Otto McGlone Wealth Management Group's Pfizer position peaked at $443K in Q4 2021.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q1 2024, filed 10 May 2024.